HKUMed Develops Innovative Organoid-based Platform for Precise Evaluation of Antibody and Vaccine Efficacy, Accelerating FDA Application of Organoid Technology
August 29, 2025
August 29, 2025
HONG KONG, Aug. 29 (TNSjou) -- The University of Hong Kong issued the following news release:
* * *
HKUMed develops innovative organoid-based platform for precise evaluation of antibody and vaccine efficacy, accelerating FDA application of organoid technology
A research team from the Department of Microbiology under the School of Clinical Medicine in the LKS Faculty of Medicine of the University of Hong Kong (HKUMed), has successfully developed the world� . . .
* * *
HKUMed develops innovative organoid-based platform for precise evaluation of antibody and vaccine efficacy, accelerating FDA application of organoid technology
A research team from the Department of Microbiology under the School of Clinical Medicine in the LKS Faculty of Medicine of the University of Hong Kong (HKUMed), has successfully developed the world� . . .